Christopher William Hoeger, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anthracyclines | 1 | 2024 | 286 | 0.800 |
Why?
|
| Receptors, Somatostatin | 7 | 2001 | 138 | 0.260 |
Why?
|
| Risk Assessment | 2 | 2024 | 24295 | 0.200 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2024 | 678 | 0.180 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2019 | 1336 | 0.160 |
Why?
|
| Cardiovascular Diseases | 2 | 2023 | 15657 | 0.150 |
Why?
|
| Somatostatin | 5 | 2001 | 459 | 0.140 |
Why?
|
| Neoplasms | 3 | 2024 | 22350 | 0.120 |
Why?
|
| Death | 1 | 2019 | 685 | 0.110 |
Why?
|
| Myocardial Contraction | 1 | 2019 | 1516 | 0.110 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2017 | 1567 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8540 | 0.070 |
Why?
|
| Cardiology | 1 | 2017 | 1701 | 0.070 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 5753 | 0.060 |
Why?
|
| Stroke Volume | 1 | 2019 | 5618 | 0.060 |
Why?
|
| Incidence | 2 | 2019 | 21525 | 0.060 |
Why?
|
| Heart Failure | 1 | 2023 | 11882 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2023 | 2730 | 0.030 |
Why?
|
| Humans | 10 | 2024 | 766766 | 0.030 |
Why?
|
| Receptors, LHRH | 1 | 1993 | 158 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2000 | 1266 | 0.020 |
Why?
|
| Binding, Competitive | 3 | 1998 | 1141 | 0.020 |
Why?
|
| Europe | 1 | 2017 | 3430 | 0.020 |
Why?
|
| Autoradiography | 2 | 2001 | 725 | 0.020 |
Why?
|
| Hypothalamic Hormones | 1 | 1989 | 145 | 0.020 |
Why?
|
| Pituitary Hormones | 1 | 1989 | 182 | 0.020 |
Why?
|
| CHO Cells | 2 | 2001 | 1376 | 0.020 |
Why?
|
| Defibrillators, Implantable | 1 | 2017 | 1499 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 3 | 2001 | 6104 | 0.020 |
Why?
|
| Structure-Activity Relationship | 3 | 2001 | 3053 | 0.020 |
Why?
|
| Melanins | 1 | 1989 | 291 | 0.020 |
Why?
|
| Cricetinae | 2 | 2001 | 2416 | 0.020 |
Why?
|
| Oligopeptides | 1 | 1992 | 1195 | 0.020 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1992 | 1142 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39309 | 0.020 |
Why?
|
| In Situ Hybridization | 2 | 2001 | 1892 | 0.020 |
Why?
|
| Risk | 1 | 2017 | 9602 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2019 | 41710 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2017 | 3957 | 0.020 |
Why?
|
| Risk Factors | 2 | 2023 | 74881 | 0.010 |
Why?
|
| Hypothalamus | 1 | 1989 | 1003 | 0.010 |
Why?
|
| Peptides | 2 | 1996 | 4344 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 15416 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 1996 | 18984 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2023 | 81635 | 0.010 |
Why?
|
| Research Design | 1 | 2017 | 6207 | 0.010 |
Why?
|
| Amino Acid Sequence | 4 | 1996 | 13411 | 0.010 |
Why?
|
| Molecular Sequence Data | 4 | 1996 | 17608 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 7431 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1993 | 5143 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 2000 | 287 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 2001 | 540 | 0.010 |
Why?
|
| Radioimmunoassay | 2 | 1990 | 861 | 0.010 |
Why?
|
| COS Cells | 1 | 2000 | 1135 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 2000 | 475 | 0.010 |
Why?
|
| Protein Binding | 2 | 2001 | 9320 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1990 | 4424 | 0.010 |
Why?
|
| Rats | 4 | 1999 | 23717 | 0.010 |
Why?
|
| Animals | 10 | 2001 | 168930 | 0.010 |
Why?
|
| Middle Aged | 2 | 2023 | 223257 | 0.010 |
Why?
|
| Adult | 2 | 2023 | 223307 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 29948 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 1999 | 575 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2000 | 1472 | 0.010 |
Why?
|
| Leiomyoma | 1 | 2001 | 644 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1990 | 1528 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1996 | 365 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 1996 | 315 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2000 | 3587 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2019 | 54871 | 0.010 |
Why?
|
| Gene Expression | 2 | 2000 | 7585 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2000 | 3616 | 0.010 |
Why?
|
| Affinity Labels | 1 | 1993 | 107 | 0.010 |
Why?
|
| Inositol Phosphates | 1 | 1993 | 175 | 0.010 |
Why?
|
| Histamine Release | 1 | 1992 | 134 | 0.010 |
Why?
|
| Cell Line | 2 | 1999 | 15563 | 0.010 |
Why?
|
| Uterine Neoplasms | 1 | 2001 | 1424 | 0.010 |
Why?
|
| Heterocyclic Compounds | 1 | 1993 | 245 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2000 | 2391 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2001 | 6507 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1999 | 3947 | 0.010 |
Why?
|
| Transforming Growth Factors | 1 | 1990 | 76 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 1992 | 828 | 0.010 |
Why?
|
| Endothelins | 1 | 1990 | 127 | 0.010 |
Why?
|
| Salmon | 1 | 1989 | 34 | 0.010 |
Why?
|
| Mice | 4 | 2000 | 81889 | 0.010 |
Why?
|
| Ligands | 1 | 1996 | 3275 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1989 | 634 | 0.000 |
Why?
|
| Protein Precursors | 1 | 1993 | 1134 | 0.000 |
Why?
|
| Chromatography, Affinity | 1 | 1989 | 524 | 0.000 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1989 | 1057 | 0.000 |
Why?
|
| Kinetics | 1 | 1996 | 6287 | 0.000 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1996 | 3738 | 0.000 |
Why?
|
| Female | 4 | 2019 | 396520 | 0.000 |
Why?
|
| Cloning, Molecular | 1 | 1993 | 4168 | 0.000 |
Why?
|
| Aged | 1 | 2019 | 171343 | 0.000 |
Why?
|
| Male | 3 | 2019 | 364142 | 0.000 |
Why?
|
| Membrane Glycoproteins | 1 | 1996 | 3702 | 0.000 |
Why?
|
| Terminology as Topic | 1 | 1993 | 1540 | 0.000 |
Why?
|
| Transfection | 1 | 1993 | 5754 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 10745 | 0.000 |
Why?
|
| Rabbits | 1 | 1990 | 4752 | 0.000 |
Why?
|
| Amino Acids | 1 | 1989 | 1711 | 0.000 |
Why?
|
| Membrane Proteins | 1 | 2000 | 7868 | 0.000 |
Why?
|
| Base Sequence | 1 | 1993 | 12415 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1992 | 8106 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2000 | 26389 | 0.000 |
Why?
|
| Software | 1 | 1993 | 4466 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1993 | 12791 | 0.000 |
Why?
|
| Infant | 1 | 2000 | 36461 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2000 | 42577 | 0.000 |
Why?
|
| Child | 1 | 2000 | 80668 | 0.000 |
Why?
|
| Signal Transduction | 1 | 1993 | 23619 | 0.000 |
Why?
|